|Articles|April 4, 2016
May 2016 — Therapeutic Innovation & Regulatory Science (TIRS): Focus on Pharmaceutical Compounding
Author(s)DIA
Advertisement
Pharmaceutical compounding is an essential aspect of medicine in the US, although with inherent risks that must be understood and managed. In May 2016, the Special Section of
Newsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
From Ambition to Advantage: How Life Sciences Leaders Are Scaling AI
2
Augmentin XR Becomes First Approval Under Commissioner’s National Priority Voucher Pilot Program
3
EU Opportunities: How EMA Support Programs Can Slash Drug Market Entry Costs by 90%
4
FDA Approves Waskyra For Treatment of Wiskott-Aldrich Syndrome
5
